Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Medullary thyroid cancer treated by capecitabine.
Labidi SI, Gravis G, Tarpin C, Brun V, Viens P. Labidi SI, et al. Anticancer Drugs. 2007 Aug;18(7):831-4. doi: 10.1097/CAD.0b013e3280adc8f3. Anticancer Drugs. 2007. PMID: 17581307
Full access to medical records does not modify anxiety in cancer patients: results of a randomized study.
Gravis G, Protière C, Eisinger F, Boher JM, Tarpin C, Coso D, Cappiello MA, Camerlo J, Genre D, Viens P. Gravis G, et al. Cancer. 2011 Oct 15;117(20):4796-804. doi: 10.1002/cncr.26083. Epub 2011 May 23. Cancer. 2011. PMID: 21607939 Clinical Trial.
Value of the sentinel lymph node procedure in patients with large size breast cancer.
Lelievre L, Houvenaeghel G, Buttarelli M, Brenot-Rossi I, Huiart L, Tallet A, Tarpin C, Jacquemier J. Lelievre L, et al. Ann Surg Oncol. 2007 Feb;14(2):621-6. doi: 10.1245/s10434-006-9232-4. Epub 2006 Nov 12. Ann Surg Oncol. 2007. PMID: 17103062
[G-CSF in oncology].
Viret F, Gonçalves A, Tarpin C, Chabannon C, Viens P. Viret F, et al. Bull Cancer. 2006 May;93(5):463-71. Bull Cancer. 2006. PMID: 16777624 Review. French.
Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.
Boudin L, Chabannon C, Sfumato P, Sabatier R, Bertucci F, Tarpin C, Provansal M, Houvenaeghel G, Lambaudie E, Tallet A, Resbeut M, Charafe-Jauffret E, Calmels B, Lemarie C, Boher JM, Extra JM, Viens P, Gonçalves A. Boudin L, et al. Eur J Cancer. 2016 Apr;57:118-26. doi: 10.1016/j.ejca.2016.01.005. Epub 2016 Feb 23. Eur J Cancer. 2016. PMID: 26918737 Clinical Trial.
[Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].
Gonçalves A, Sabatier R, Charafe-Jauffret E, Gilabert M, Provansal M, Tarpin C, Extra JM, Viens P, Bertucci F. Gonçalves A, et al. Bull Cancer. 2013 May;100(5):453-64. doi: 10.1684/bdc.2013.1740. Bull Cancer. 2013. PMID: 23695030 Review. French.
Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.
Gilabert M, Bertucci F, Esterni B, Madroszyk A, Tarpin C, Jacquemier J, Extra JM, Viens P, Gonçalves A. Gilabert M, et al. Anticancer Res. 2011 Mar;31(3):1079-86. Anticancer Res. 2011. PMID: 21498742
Genome profiling of ERBB2-amplified breast cancers.
Sircoulomb F, Bekhouche I, Finetti P, Adélaïde J, Ben Hamida A, Bonansea J, Raynaud S, Innocenti C, Charafe-Jauffret E, Tarpin C, Ben Ayed F, Viens P, Jacquemier J, Bertucci F, Birnbaum D, Chaffanet M. Sircoulomb F, et al. BMC Cancer. 2010 Oct 8;10:539. doi: 10.1186/1471-2407-10-539. BMC Cancer. 2010. PMID: 20932292 Free PMC article.
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci F, Jacquemier J, Xerri L, Dontu G, Stassi G, Xiao Y, Barsky SH, Birnbaum D, Viens P, Wicha MS. Charafe-Jauffret E, et al. Clin Cancer Res. 2010 Jan 1;16(1):45-55. doi: 10.1158/1078-0432.CCR-09-1630. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028757 Free PMC article.
52 results
Jump to page
Feedback